CD38 Targeting Holds Potential for the Treatment of Aggressive Refractory Cutaneous T-Cell Lymphomas by Olesya Pavlova

No abstract

J Invest Dermatol. 2023 Mar 16:S0022-202X(23)00107-0. doi: 10.1016/j.jid.2023.02.011. Online ahead of print.

NO ABSTRACT

PMID:36933969 | DOI:10.1016/j.jid.2023.02.011

Read More